Document is current
Any future updates will be listed below
-
Authors
Stamatis, Caitlin A. https://orcid.org/0000-0001-8251-0909
Heusser, Andrew C. https://orcid.org/0000-0001-6353-688X
Simon, Tony J.
Ala’ilima, Titiimaea
Kollins, Scott H.
-
Funding
Funding for this research was provided by:
Akili Interactive Labs
- License Information
-
More Information
Article History
Received: 9 November 2023
Revised: 18 July 2024
Accepted: 31 July 2024
First Online: 11 August 2024
Competing interests
: Akili Interactive Labs provided research support and played a role in the conceptualization and design of the trials. In addition, the authors declare the following employment and financial interests: C.A.S., A.C.H., T.J.S., T.A., and S.H.K. are current or former employees at Akili Interactive Labs and may own stock or equity. The views and opinions expressed within this manuscript are those of the authors and do not necessarily represent those of the sponsor.
: All clinical trial participants (or legal guardians, for the pediatric and adolescent trials) provided written informed consent, and procedures were approved by each site’s Institutional Review Board. For the commercial data, retrospective IRB-exempt status was granted under 45 CFR 46 116(f)[2018 Requirements] 45 CFR 46.116(d) [Pre-2018 Requirements] for the analysis of de-identified data by the WCG Institutional Review Board on April 21, 2023 (Study Number: 1353416).
